Commentary After a tumultuous period for U.S.-listed Chinese companies, many U.S. investors are finally concluding that Chinese companies are not worthy of a place in their portfolios. On July 30, the U.S. Securities and Exchange Commission issued a broad halt on new Chinese IPOs listing in the United States until risks posed to investors can be better understood and disclosed. And that’s easier said than done. It is a truly shocking development. Several months ago, it was difficult to imagine what could derail the flow of foreign capital into Chinese stocks. The catalyst was the Chinese Communist Party (CCP) and its regulatory regime. The beginning could be traced to last fall after regulators scuttled a planned IPO for Ant Group, the digital payments application, and attempted to rein in Alibaba founder Jack Ma. While Ant never IPO’ed so no retail investors were directly hurt, its early institutional investors (including U.S. …